Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1000 of 1,261
  1. US 7727992

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  2. US 7727542

    Bioactive materials, methods of making bioactive materials and method of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  3. US 7727514

    Compositions comprising a UV-absorbing chromophore

    United States of America Department of Agriculture · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  4. US 7727534

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  5. US 7727544

    Treatment of myopia

    The Regents of the University of California · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  6. US 7727554

    Sustained-release nanoparticle compositions and methods for using the same

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  7. US 7727525

    Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics

    The Regents of the University of California · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  8. US 7728017

    Inhibitors of c-Met and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  9. US 7728144

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  10. US 7727999

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  11. US 7728004

    Crystalline form of a quinolinone-carboxamide compound

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  12. US 7728127

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  13. US 7728104

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  14. US 7728120

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  15. US 7728006

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  16. US 7728148

    Acyclic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  17. US 7723300

    Regulators of the non-genomic action of progesterone and methods of use

    UNIVERSITY OF CONNECTICUT · Granted May 25, 2010 · Expires May 20, 2030

    granted
  18. US 7723104

    Cancer specific promoters

    The Board of Regents of the University of Texas System · Granted May 25, 2010 · Expires May 20, 2030

    granted
  19. US 7723071

    DNA molecules encoding opioid receptors and methods of use thereof

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted
  20. US 7723022

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted May 25, 2010 · Expires May 20, 2030

    granted
  21. US 7723018

    Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade

    Rigel Pharmaceuticals, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  22. US 7723313

    Methods and compositions for inhibiting angiogenesis

    Northwestern University · Granted May 25, 2010 · Expires May 20, 2030

    granted
  23. US 7722865

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  24. US 7723311

    Delivery of bioactive substances to target cells

    United States of America as represented by the Secretary of the Air Force · Granted May 25, 2010 · Expires May 20, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.